Table 4.
Antioxidant variables at baseline and at the end of the study in patients treated with the DHA supplement and in controls.
| Variables | Control Group (n = 15) | DHA Group (n = 19) | Within-Group p Value |
Between-Group p Value |
||||
|---|---|---|---|---|---|---|---|---|
| Baseline | End of Study | Baseline | End of Study | Control Group | DHA Group | Baseline | End of Study | |
| TAC, µ Cu reducing equiv. | 109.20 (7.80) | 115.30 (4.76) | 102.80 (7.37) | 141.40 (8.82) | 0.348 | <0.0001 | 0.556 | 0.012 |
| MDA, µM | 4.02 (0.23) | 4.36 (0.29) | 3.84 (0.17) | 3.15 (0.24) | 0.322 | 0.004 | 0.701 | 0.0007 |
| GSH, total, mmol/mg protein | 10.67 (0.55) | 10.12 (0.50) | 9.44 (0.55) | 10.30 (0.52) | 0.246 | 0.229 | 0.126 | 0.912 |
| GSH, free, mmol/mg protein | 8.87 (0.43) | 7.93 (0.45) | 7.90 (0.49) | 9.01 (0.48) | 0.118 | 0.121 | 0.224 | 0.071 |
| GSH/GSSG ratio | 10.98 (0.93) | 8.46 (0.96) | 11.09 (0.94) | 15.11 (1.22) | 0.029 | 0.018 | 0.986 | <0.0001 |
TAC: total antioxidant capacity; Cu: copper; equiv: equivalents; MDA: malondialdehyde; GSH: glutathione; GSSG: oxidized glutathione. Data expressed as mean and standard error of the mean (SEM) in parenthesis.